Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06869512 · ClinicalTrials.gov registry record · NA

Cooperative Extension and Cancer Survivorship

A NA study of Cancer Survivorship, sponsored by University of Oklahoma.

Recruiting
Registry status
NA
Development phase
80
Enrollment target
1
Study location

NCT06869512 is a NA study of Cancer Survivorship that is actively recruiting participants, run by University of Oklahoma. The registered enrollment target is 80 participants, below the 254-participant average among 11 other Cancer Survivorship trials with a reported enrollment target (69% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06869512, a NA study of Cancer Survivorship, is actively recruiting participants, sponsored by University of Oklahoma.

RECRUITING
Registry status
NA
Development phase
80 participants
Enrollment target
1
Study location

Study Summary

The goal of this clinical trial is to learn if a cancer survivor program, delivered via Cooperative Extension, is feasible and if it can improve health outcomes in cancer survivors who are post-active treatment. Aim 1: Evaluate the feasibility and acceptability of SUCCESS. Hypothesis 1: SUCCESS will be feasible and acceptable as evidenced by delivery of the intervention among Educators (implementation), including in agreement with the curriculum in Phase 1 (fidelity) with \>85% attendance (demand) among participants with \>80% rating the intervention as acceptable or highly acceptable on 5-point Likert-type scale (acceptability). Aim 2: Determine the preliminary efficacy of SUCCESS for improving HRQOL (primary outcome) and other psychosocial and health-related endpoints (e.g., financial toxicity) (secondary outcomes). Hypothesis 2: Compared to matched controls, adults LWBC who complete SUCCESS will have significant improvements in HRQOL per the PROMIS Global Health v1.2 at follow-up (i.e., after 6 weeks). Aim 3: Examine changes in conserved transcriptional response to adversity (CTRA) gene expression in a subset of interventions participants at follow-up. Hypothesis 3: Adults LWBC who complete SUCCESS will experience significant CTRA down-regulation. This is a single arm trial and there is no comparison group. Participants will be asked to do survey- and Zoom-based data collection before and after completing the 6-week program.

Conditions Studied

Cancer Survivorship

Interventions

  • BEHAVIORAL SUCCESS

Study Locations (1)

Oklahoma

  • University of Oklahoma - Tulsa

Trial Details

FieldValue
Enrollment Target 80 participants
Start Date 2025-02-24
Est. Completion 2026-12-31
Phase NA

Sponsor

University of Oklahoma

358 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06869512

The ClinicalTrials.gov registry entry for NCT06869512 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 254-participant average among 11 other Cancer Survivorship trials with a reported enrollment target (69% lower). The listed sponsor is University of Oklahoma, which has 358 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Cancer Survivorship appearing as the primary indexed condition, and to 1 intervention - of which SUCCESS is the first listed.

NCT06869512 reports 1 study location spanning 1 distinct geographic area - top geographies include Oklahoma.

Frequently Asked Questions

What is clinical trial NCT06869512 about?

NCT06869512 is a clinical study titled "Cooperative Extension and Cancer Survivorship". The goal of this clinical trial is to learn if a cancer survivor program, delivered via Cooperative Extension, is feasible and if it can improve health outcomes in cancer survivors who are post-active treatment. Aim 1: Evaluate the feasibility and acceptability of SUCCESS. Hypothesis 1: SUCCESS wil...

What is the current status of trial NCT06869512?

This trial is currently recruiting. It is a NA study. The enrollment target is 80 participants. The study started on 2025-02-24. Estimated completion is 2026-12-31.

What conditions does trial NCT06869512 study?

This clinical trial studies the following conditions: Cancer Survivorship.

What interventions are being tested in trial NCT06869512?

The interventions under investigation include: SUCCESS (BEHAVIORAL).

Who is sponsoring clinical trial NCT06869512?

This trial is sponsored by University of Oklahoma, which has 358 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06869512 being conducted?

This trial has 1 study location across Oklahoma. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Cancer Survivorship

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Cancer Survivorship

All registered trials for this condition

Oklahoma

All trials with a study site in Oklahoma

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.